Literature DB >> 23371379

[Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment].

B Leplow1, M Böttcher, R Schönfeld.   

Abstract

BACKGROUND: Spasmodic torticollis patients were investigated with respect to the number of adjunct treatments used before and after the introduction of botulinum toxin therapy (Btx). The study was designed in a similar way to an earlier investigation by Birner et al. (Nervenarzt 70:903-908, 1999).
MATERIAL AND METHODS: A total of 247 patients with idiopathic spasmodic torticollis were assessed at three time points for the diagnosis: before 1988 (n = 63), between 1989 and 1998 (n = 107) and after 1999 (n = 77).
RESULTS: Independent of the year of diagnosis patients underwent a mean of 14.3 different treatments. In addition to Btx most of the patients were subjected to massage, physiotherapy, medication and a large number of non-medical treatments including praying. No associations to clinical or personal variables were found. Those patients with emotional disorders prior to onset of dystonia displayed a higher rate of medical and non-medical treatments in addition to Btx.
CONCLUSIONS: The results confirmed those found by Birner et al.. In order to enhance compliance patients should undergo psychoeducation with respect to illness behaviour and specific history taking with respect to emotional disorders prior to dystonia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371379     DOI: 10.1007/s00115-012-3708-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  25 in total

1.  Impact of cervical dystonia on quality of life.

Authors:  Laura Camfield; Yoav Ben-Shlomo; Thomas T Warner
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

2.  Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.

Authors:  Daniel Truong; Matthew Brodsky; Mark Lew; Allison Brashear; Joseph Jankovic; Eric Molho; Olga Orlova; Sofia Timerbaeva
Journal:  Parkinsonism Relat Disord       Date:  2010-03-31       Impact factor: 4.891

3.  Relation between depression and anxiety in dystonic patients: implications for clinical management.

Authors:  E Moraru; P Schnider; A Wimmer; T Wenzel; P Birner; H Griengl; E Auff
Journal:  Depress Anxiety       Date:  2002       Impact factor: 6.505

4.  Attachment representation and cortisol response to the adult attachment interview in idiopathic spasmodic torticollis.

Authors:  C E Scheidt; E Waller; H Malchow; U Ehlert; F Becker-Stoll; J Schulte-Mönting; C H Lücking
Journal:  Psychother Psychosom       Date:  2000 May-Jun       Impact factor: 17.659

5.  [Torticollis spasmodicus, blepharospasm and hemifacial spasm. Subjective evaluation of therapy by patients].

Authors:  P Birner; P Schnider; J Müller; J Wissel; I Fuchs; E Auff
Journal:  Nervenarzt       Date:  1999-10       Impact factor: 1.214

6.  What are the determinants of quality of life in people with cervical dystonia?

Authors:  Y Ben-Shlomo; L Camfield; T Warner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

7.  Quality of life in patients with focal dystonia.

Authors:  Tatjana Pekmezovic; Marina Svetel; Natasa Ivanovic; Natasa Dragasevic; Igor Petrovic; Darija Kisic Tepavcevic; Vladimir S Kostic
Journal:  Clin Neurol Neurosurg       Date:  2008-11-07       Impact factor: 1.876

8.  The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.

Authors:  J Müller; G Kemmler; J Wissel; A Schneider; B Voller; J Grossmann; J Diez; N Homann; G K Wenning; P Schnider; W Poewe
Journal:  J Neurol       Date:  2002-07       Impact factor: 4.849

9.  Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia.

Authors:  I M Skogseid; U F Malt; J Røislien; E Kerty
Journal:  Eur J Neurol       Date:  2007-08-15       Impact factor: 6.089

10.  Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles.

Authors:  R Lencer; S Steinlechner; J Stahlberg; H Rehling; M Orth; T Baeumer; H-J Rumpf; C Meyer; C Klein; A Muenchau; J Hagenah
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05-21       Impact factor: 10.154

View more
  5 in total

1.  Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia.

Authors:  Bernd Leplow; Anna Eggebrecht; Johannes Pohl
Journal:  Patient Prefer Adherence       Date:  2017-09-14       Impact factor: 2.711

2.  Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy.

Authors:  Harald Hefter; Isabelle Schomaecker; Max Schomaecker; Sara Samadzadeh
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

3.  Individual Response to Botulinum Toxin Therapy in Movement Disorders: A Time Series Analysis Approach.

Authors:  Bernd Leplow; Johannes Pohl; Julia Wöllner; David Weise
Journal:  Toxins (Basel)       Date:  2022-07-24       Impact factor: 5.075

4.  The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot Study.

Authors:  Harald Hefter; Isabelle Schomaecker; Max Schomaecker; Dietmar Rosenthal; Sara Samadzadeh
Journal:  Medicina (Kaunas)       Date:  2022-01-07       Impact factor: 2.430

5.  The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.

Authors:  Harald Hefter; Isabelle Schomaecker; Max Schomaecker; Dietmar Rosenthal; Sara Samadzadeh
Journal:  Toxins (Basel)       Date:  2021-07-16       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.